Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells.

Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells. Abstract Text:

    jingbo liuJingbo Liu,ya-guang liuYa-Guang Liu,ruochun huangRuochun Huang,chen yaoChen Yao,shiyong liShiyong Li,weimin yangWeimin Yang,dongzi yangDongzi Yang,ruo-pan huangRuo-Pan Huang,jingbo liuJingbo Liu,ya-guang liuYa-Guang Liu,ruochun huangRuochun Huang,chen yaoChen Yao,shiyong liShiyong Li,weimin yangWeimin Yang,dongzi yangDongzi Yang,ruo-pan huangRuo-Pan Huang,

    A growing body of evidence suggests that early growth response-1 (Egr-1), a transcription factor, may function as a tumor suppressor. The aim of this study was to gain more evidence to support the role of Egr-1 in the suppression of cancer cell growth and to examine the potential correlation between Egr-1 and gelsolin. Materials and Methods: Histochemical staining coupled with breast cancer tissue arrays were used to examine the expression levels of Egr-1 and gelsolin. Reporter assays and gel shift were used to study the transcriptional activity of Egr-1 on the regulation of gelsolin. Results: Our data showed that most normal mammary tissues expressed high levels of Egr-1, while the majority of breast cancer tissues expressed very small amounts of Egr-1. The expression pattern of Egr-1 in human breast cancer tissues was highly correlated with gelsolin expression. Induction of Egr-1 by serum stimulation accompanied the increase of gelsolin expression. In cells lacking the induction of Egr-1 in response to serum stimulation, gelsolin expression remained unchanged. Furthermore, gelsolin promoter activity was profoundly reduced in Egr-1 null mouse embryonic fibroblasts compared to Egr-1 wild-type mouse embryonic fibroblasts. Gel shift experiments indicated that Egr-1 can directly bind to the gelsolin promoter. Conclusion: Our results suggest that Egr-1 may be an important breast cancer marker and that an as yet uncharacterized pathway involved in Egr-1 and gelsolin expression exists which leads to breast cancer cell development.

    Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells. Publishing Authors By Initials

    j liuJ Liu,yg liuYG Liu,r huangR Huang,c yaoC Yao,s liS Li,w yangW Yang,d yangD Yang,rp huangRP Huang,j liuJ Liu,yg liuYG Liu,r huangR Huang,c yaoC Yao,s liS Li,w yangW Yang,d yangD Yang,rp huangRP Huang,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Cancer genomics & proteomics

    VOLUME: 4

    Page Numbers: 377-86

    Journal Abbreviation:

    ISSN: 1109-6535

    DAY: 21

    MONTH: 01

    YEAR: 2008

    Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101188791

    Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells.

    AFFILIATION: Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, U.S.A.

    Country: Greece

    Greece Research PublicationGreece Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cancer Genomics Proteomics

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Concurrent Down-regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News